Toripalimab Set For ASCO Buzz With New Nasopharyngeal Data

First-Line PFS Improvements

 
• By Ian Haydock
  
NPC
Toripalimab Provides New Hope For First-Line NPC • Source: Alamy

More from Anticancer

More from Therapy Areas